Retina Labs will be sponsoring and exhibiting at the upcoming Rise STAR RATINGS MASTER CLASS conference in San Diego, December 13-15, 2022.
End-to-end solution enables health plans to improve Star ratings though better member compliance on diabetic eye exams and other preventive screenings.
End-to-end solution enables health plans to improve Star ratings though better member compliance on diabetic eye exams and other preventive screenings.
In response to the COVID-19 pandemic, Retina Labs has announced its latest in teleophthalmology innovation with the introduction of a telemedicine-based e-consultation platform specially designed for eye health.
Retina Labs is pleased to announce that it has moved its Canadian offices to the Montreal Technoparc. The Techoparc is Canada’s most prestigious science park and serves as an innovation and research hub for over 90 established and emerging companies in the medtech, software, life science, telecommunications and aerospace industries.
Retina Labs is pleased to announce that it will sponsor exhibit at the upcoming America’s Health Insurance Plans (AHIP) Institute and Expo to be held in Nashville, TN June 19th to 21st, 2019. Known as the Essential Event for the Health Care Industry, AHIP’s Institute & Expo consistently delivers results for hundreds of solutions providers.
Retina Labs is excited to be one of a select group of companies mentioned in this report. Appearing in the category of Telemedicine / Telerefraction, Retina Labs has emerged a leader in the area of ocular telehealth.
November is officially Diabetic Eye Disease Awareness Month. Diabetic eye disease represents a group of eye conditions that affects those with diabetes.
Diabetic retinopathy is on the rise in Ontario. It is estimated that there are 1.2 million people with diabetes in Ontario, with 20% of those expected to experience vision loss.
Retina Labs is pleased to announce that it has been selected by the Ontario Telemedicine Network (OTN) as the solution for its provincial Teleophthalmology Program.
Dr. Marie Carole Boucher had had enough. Enough of seeing patients lose their sight because of a disease that was easily curable.
Retina Labs, a market innovator in teleophthalmology and virtual eye care solutions, has brought on Richard Pridham as its President and CEO and as an investor in the company.
Maisonneuve Rosemont, one of Montreal’s largest hospitals centres, has chosen iVision®, Retina Labs industry leading teleophthalmology and virtual care platform.
The McGill Integrated University Health Network or Réseau Universitaire Intégré de Santé (known as “RUIS”), has chosen Retina Labs iVision Solution for its teleophthalmology program.
The First Nations of Quebec and Labrador Health and Social Services Commission have partnered with Retina Labs to provide screening for diabetic retinopathy.
